ST-503 will be evaluated in a phase 1/2 trial with the first patient scheduled to receive the therapy in the coming months. The Food and Drug Administration (FDA) has granted Fast Track designation to ...
Please provide your email address to receive an email when new articles are posted on . Multiple diagnostic tools are necessary to assess diabetic peripheral neuropathy in patients. The choice of ...
—This cross-sectional study investigated a possible association between a high GI symptom burden in types 1 and 2 diabetes with the presence of various neuropathies. A high gastrointestinal (GI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results